TherapeuticsMD, Inc. (TXMD) Social Stream
TherapeuticsMD Inc (TXMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TherapeuticsMD Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 31 weeks, TXMD's average price target has gone down $1.47.
Over the past 48 weeks, TXMD's average upside potential has been 633.1%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TXMD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, TXMD's average broker recommendation rating improved by 0.6.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TXMD as an investment opportunity.
- TherapeuticsMD Inc's upside potential (average analyst target price relative to current price) is greater than 594.63% of all US stocks.
- In the context of all US stocks, TherapeuticsMD Inc's average analyst price target is greater than 13.24% of them.
- TherapeuticsMD Inc's number of analysts covering the stock is greater than 80.72% of Pharmaceutical Products stocks.
- TherapeuticsMD Inc's variance in analysts' estimates is lower than -271.64% of stocks in the small market cap category.
Is TXMD a Buy, Hold or Sell? See the POWR Ratings now!